Page 7 - Prime Editors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Prime Medicine (NYSE:PRME) Trading Down 6 4%

Prime Medicine, Inc. (NYSE:PRME – Get Free Report)’s share price fell 6.4% during trading on Tuesday . The company traded as low as $6.89 and last traded at $7.01. 78,928 shares traded hands during mid-day trading, a decline of 85% from the average session volume of 523,514 shares. The stock had previously closed at $7.49. […]

Stifel nicolausSg americas securitiesRoyal bankChina universal asset management coJpmorgan chase coAmeritas investment partners incMedicine incLife insurance coPrime medicineGet free reportInvestment partnersChina universal asset managementPrime editorsPrime editorPrime medicine dailyNyse prme

Greenwich Wealth Management LLC Has $4 19 Million Holdings in Prime Medicine, Inc (NYSE:PRME)

Greenwich Wealth Management LLC boosted its position in shares of Prime Medicine, Inc. (NYSE:PRME – Free Report) by 111.1% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 439,021 shares of the company’s stock after buying an additional 231,021 shares during the period. Greenwich […]

Stifel nicolausPenserra capital managementBarclays plcSecurities exchange commissionAmeritas investment partners incLife insurance coGreenwich wealth managementRoyal bankMedicine incJpmorgan chase coPrime medicineFree reportWealth managementInvestment partnersCapital managementGet free report

Analysts Set Prime Medicine, Inc (NYSE:PRME) PT at $18 14

Analysts Set Prime Medicine, Inc (NYSE:PRME) PT at $18 14
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesStifel nicolausMedicine incAmerican international group incAllspring global investments holdingsJpmorgan chase coSumitomo mitsui trust holdings incPrincipal financial group incLife insurance coPrime medicineGet free reportGlobal investments holdingsMitsui trust holdingsInternational groupFinancial groupMedicine trading down

Prime Medicine, Inc (NYSE:PRME) Given Average Recommendation of Moderate Buy by Brokerages

Prime Medicine, Inc (NYSE:PRME) Given Average Recommendation of Moderate Buy by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Stifel nicolausPenserra capital managementJpmorgan chase coLife insurance coAmeritas investment partners incBarclays plcMedicine company profileDeutsche bankMedicine incPrime medicineGet free reportCapital managementInvestment partnersMedicine stock downGet freePrime editors

Prime Medicine s Investment Potential: A Deep Dive Into Innovation And Gene Editing

Prime Medicine s Investment Potential: A Deep Dive Into Innovation And Gene Editing
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Igor kutyaevMyeloid therapeutics incImplications of prime medicine technologyPrime editingPrime medicineCloser lookChronic granulomatous diseaseGlycogen storage diseaseRare pediatric drugPrime editorsInvestigational new drugBroader biotechMyeloid therapeutics